These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 19646658
1. Influence of pharmacological PPARalpha activators on carnitine homeostasis in proliferating and non-proliferating species. Ringseis R, Eder K. Pharmacol Res; 2009 Sep; 60(3):179-84. PubMed ID: 19646658 [Abstract] [Full Text] [Related]
2. The role of peroxisome proliferator-activated receptor alpha in transcriptional regulation of novel organic cation transporters. Eder K, Ringseis R. Eur J Pharmacol; 2010 Feb 25; 628(1-3):1-5. PubMed ID: 19941851 [Abstract] [Full Text] [Related]
5. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Ringseis R, Pösel S, Hirche F, Eder K. Pharmacol Res; 2007 Aug 25; 56(2):175-83. PubMed ID: 17644405 [Abstract] [Full Text] [Related]
7. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Luci S, Hirche F, Eder K. Ann Nutr Metab; 2008 Aug 25; 52(1):58-67. PubMed ID: 18309235 [Abstract] [Full Text] [Related]
8. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases intestinal carnitine absorption in rats. Ringseis R, Lüdi S, Hirche F, Eder K. Pharmacol Res; 2008 Jul 25; 58(1):58-64. PubMed ID: 18620058 [Abstract] [Full Text] [Related]
9. Mouse γ-butyrobetaine dioxygenase is regulated by peroxisome proliferator-activated receptor α through a PPRE located in the proximal promoter. Wen G, Kühne H, Rauer C, Ringseis R, Eder K. Biochem Pharmacol; 2011 Jul 15; 82(2):175-83. PubMed ID: 21549104 [Abstract] [Full Text] [Related]
10. Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. Makowski L, Noland RC, Koves TR, Xing W, Ilkayeva OR, Muehlbauer MJ, Stevens RD, Muoio DM. FASEB J; 2009 Feb 15; 23(2):586-604. PubMed ID: 18945875 [Abstract] [Full Text] [Related]
11. Genomic and non-genomic interactions of PPARalpha with xenobiotic-metabolizing enzymes. Barbier O, Fontaine C, Fruchart JC, Staels B. Trends Endocrinol Metab; 2004 Sep 15; 15(7):324-30. PubMed ID: 15350604 [Abstract] [Full Text] [Related]
19. Recent progress in research on peroxisome proliferator-activated receptor alpha-selective ligands. Miyachi H. IDrugs; 2004 Aug 15; 7(8):746-54. PubMed ID: 15334308 [Abstract] [Full Text] [Related]
20. Hypolipidemia induced by PPARalpha agonists: HNF-4alpha as an alternative to PPARalpha. Bar-Tana J. Curr Opin Investig Drugs; 2004 Sep 15; 5(9):941-6. PubMed ID: 15503648 [Abstract] [Full Text] [Related] Page: [Next] [New Search]